Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 4, 2006, Pages 926-932

  Ohsaki, Yusuke ^a   Shirakawa, Hitoshi ^a   Hiwatashi, Kazuyuki ^a   Furukawa, Yuji ^a   Mizutani, Takeo ^b   Komai, Michio ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b ALA Research Center   (Japan)

Author keywords

DNA microarray; Inflammation; Interleukin 6; Vitamin K

Indexed keywords

CARBOXYLATION; DNA; INORGANIC ACIDS; LIVING SYSTEMS STUDIES; PROTEINS; TISSUE;

DNA MICROARRAY; INFLAMMATION; INTERLEUKIN-6; VITAMIN K;

VITAMINS;

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; VITAMIN K GROUP;

ANIMAL; ARTICLE; BLOOD CLOTTING; CELL LINE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; LIVER; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RAT; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD COAGULATION; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; RATS; RATS, WISTAR; RNA, MESSENGER; VITAMIN K;

MAMMALIA;

EID: 33646141588     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.926     Document Type: Article

References (27)

1. Suttie, J. W., Synthesis of vitamin K-dependent proteins. FASEB J., 7, 445-452 (1993).
2. Wu, S. M., Stanley, T. B., Mutucumarana, V. P., and Stafford, D. W., Characterization of the γ-glutamyl carboxylase. Thromb. Haemost., 78, 599-604 (1997).
3. Suttie, J. W., The importance of menaquinone in human nutrition. Annu. Rev. Nutr., 15, 399-417 (1995).
4. Yamamoto, R., Komai, M., Kojima, K., Furukawa, Y., and Kimura, S., Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats. J. Nutr. Sci. Vitaminol. (Tokyo), 43, 133-143 (1997).
5. Ronden, J. E., Thijssen, H. H., and Vermeer, C., Tissue distribution of K-vitamers under different nutritional regimens in the rat. Biochim. Biophys. Acta, 1379, 16-22 (1998).
6. Huber, A. M., Davidson, K. W., O'Brien-Morse, M. E., and Sadowski, J. A., Tissue phylloquinone and menaquinones in rats are affected by age and gender. J. Nutr., 129, 1039-1044 (1999).
7. Sambrook, J., Fritsch, E. F., and Maniatis, T., Molecular cloning: a laboratory manual, second ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor (1989).
8. Jukes, T. H., Vitamin K. In "The Vitamins: Fundamental Aspects in Nutrition and Health" 2nd ed., ed. Combs, Jr. G. F., Academic Press, San Diego, pp. 228-244 (1998).
9. Komai, M., Shirakawa, H., and Kimura, S., Newly developed model for vitamin K deficiency in germfree mice. Int. J. Vitam. Nutr. Res., 58, 55-59 (1988).
10. Schultz, D. R., and Arnold, P. I., Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin. Arthritis. Rheum., 20, 129-147 (1990).
11. Bacher, M., Meinhardt, A., Lan, H. Y., Mu, W., Metz, C. N., Chesney, J. A., Calandra, T., Gemsa, D., Donnelly, T., Atkins, R. C., and Bucala, R., Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol., 150, 235-246 (1997).
12. Macdonald, J., Galley, H. F., and Webster, N. R., Oxidative stress and gene expression in sepsis. Br. J. Anaesth., 90, 221-232 (2003).
13. Murakami, K., Okajima, K., Uchiba, M., Johno, M., Nakagaki, T., Okabe, H., and Takatsuki, K., Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am. J. Physiol., 272, L197-202 (1997).
14. Grey, S. T., Tsuchida, A., Hau, H., Orthner, C. L., Salem, H. H., and Hancock, W. W., Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J. Immunol., 153, 3664-3672 (1994).
15. Yamaji, K., Wang, W., Liu, Y., Abeyama, K., Hashiguchi, T., Uchimura, T., Biswas, K. K., Iwamoto, H., and Maruyama, I., Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thromb. Res., 115, 319-325 (2005).
16. Li, J., Lin, J. C., Wang, H., Peterson, J. W., Furie, B. C., Furie, B., Booth, S. L., Volpe, J. J., and Rosenberg, P. A., Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J. Neurosci., 23, 5816-5826 (2003).
17. Ollivier, V., Parry, G. C., Cobb, R. R., de Prost, D., and Mackman, N., Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem., 271, 20828-20835 (1996).
18. Bshesh, K., Zhao, B., Spight, D., Biaggioni, I., Feokistov, I., Denenberg, A., Wong, H. R., and Shanley, T. P., The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol., 72, 1027-1036 (2002).
19. Yoon, S. W., Goh, S. H., Chun, J. S., Cho, E. W., Lee, M. K., Kim, K. L., Kim, J. J., Kim, C. J., and Poo, H., α-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-α production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J. Biol. Chem., 278, 32914-32920 (2003).
20. 2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology, 40, 243-251 (2004).
21. Nakashima, T., Kobayashi, Y., Yamasaki, S., Kawakami, A., Eguchi, K., Sasaki, H., and Sakai, H., Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem. Biophys. Res. Commun., 275, 768-775 (2000).
22. Palmqvist, P., Persson, E., Conaway, H. H., and Lerner, U. H., IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae. J. Immunol., 169, 3353-3362 (2002).
23. 2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur. J. Pharmacol., 263, 181-185 (1994).
24. 2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone, 27, 769-776 (2000).
25. 2) acts directly on circulating human osteoclast precursors. Calcif. Tissue Int., 73, 78-85 (2003).
26. Koshihara, Y., Hoshi, K., Okawara, R., Ishibashi, H., and Yamamoto, S., Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J. Endocrinol., 176, 339-348 (2003).
27. Reddi, K., Henderson, B., Meghji, S., Wilson, M., Poole, S., Hopper, C., Harris, M., and Hodges, S. J., Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine, 7, 287-290 (1995).